Lineage Cell Therapeutics Investor

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Technology: Regenerative Medicine
Industry: Biotechnology, Health Care, Professional Services, Science and Engineering
Headquarters: United States
Founded Date: 1990-01-01
Employees Number: 101-250
Funding Status: IPO
Investor Type: For Profit
Number Of Exits: 1
Investors Number: 1
Total Funding: 72908804 USD
Estimated Revenue: Less than $1M
Last Funding Date: 2019-05-10
Last Funding Type: Grant

Visit Website
https://twitter.com/BioTimeBTX
Register and Claim Ownership